Come see the Sphinx and save on Sovaldi.
That’s the implicit pitch of an unusual campaign that’s spurring dozens of hepatitis C patients to fly to Egypt each month in pursuit of a cure they can afford.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
I suggest all those interested in the treatment of HCV look at Aethlon Medical’s Hemopurifier® and its ability to remove both the HCV and its toxins that impair the ability of the immune system to recognize the pathogen.
I’m am interested in your treatment information for my husband with Hepatitis c Geno 2 . He had a heart attack after taking Sofosbuvir Solvaldi. Can you email me. Thank you